Blood calcium dynamics in cows receiving an aqueous calcium suspension for voluntary consumption or a calcium bolus following parturition.

The form of oral calcium (Ca) supplement and the Ca source influence Ca absorption dynamics resulting in different postpartum calcemia. The objective of this study was to investigate whether an oral Ca supplement (mainly CaCO3) offered for voluntary consumption would maintain or increase postpartum blood Ca to the same degree as a Ca bolus (mainly CaCl2) providing an equivalent dose of a Ca. A total of 72 Holstein cows were blocked by expected parturition date and parity. Within each block of 3 animals, cows were randomly assigned to one of three treatments, including an oral Ca supplement offered for voluntary consumption (Ca-drink, n = 23), an oral Ca bolus (Ca-bolus, n = 24), or an untreated group (CON, n = 25). Treatments were administered once within 15 min postpartum. The Ca-drink provided 45 g of Ca (CaCO3 source) and was mixed in 20 L of lukewarm water and offered to cows for 30 min. The Ca-bolus provided 43 g of Ca (71% from CaCl2 and 29% from CaSO4) and was administered once. Both Ca-bolus and CON cows received 20-l of lukewarm water at parturition to standardize the volume of fluids (Ca-drink or 20-l lukewarm water) offered at parturition. Dairy cows offered Ca-drink had a 28% higher fluid consumption than Ca-bolus and CON cows. Milk yield and milk composition expressed in percentage protein, fat, lactose, and urea did not differ, whilst there was a small but significant increase in DMI in cows receiving the Ca-drink compared to CON, while Ca-bolus did not differ from other groups. This was consistent with reduced BW losses between week 1 and 3 in cows receiving the Ca-drink suspension. Treatment by time interactions were present for blood Ca, glucose, and urea concentrations. Blood Ca was relatively stable in Ca-drink cows, while higher fluctuations were observed in Ca-bolus cows. In Ca-bolus cows, blood Ca increased from 15 min to 6 h, decreased from 6 to 24 h, and finally increased again from 24 to 48 h. At 24 h post administration, blood Ca was greater in cows receiving the Ca-drink than cows receiving the Ca-bolus. Blood glucose was greater in Ca-bolus cows at 15 min after treatment administration compared with Ca-bolus and CON, while blood urea was higher in CON than Ca-drink and Ca-bolus throughout the sampling period. These results indicate that voluntary oral Ca resulted in a relatively stable calcemia, whereas higher fluctuations were observed in cows receiving the Ca-bolus. Due to a lack of differences between Ca-drink and Ca-bolus compared with CON, it is not possible to conclude regarding the efficacy in maintaining postpartum blood Ca.

Effect of a calcium-energy supplement drink at calving on lactation performance: Milk yield and composition, odds to reach a next lactation, and calving interval.

Supplementation of Ca products to cows after calving is common in calving protocols. This study evaluated the effect of a Ca-energy drink voluntarily consumed on milk yield and composition, odds to reach a next lactation, and calving interval. This prospective randomized study included a blinded placebo and was conducted in 10 commercial dairy farms that included 504 Holstein dairy cows. Cows were blocked within farm by calving sequence and parity (primiparous or multiparous). Within each block of 2 animals, cows were randomly assigned to 1 of 2 treatments: a Ca-energy supplement drink (CAE, n = 255) providing 45 g of Ca and other components (dextrose, lactose, protein, fat, other minerals and vitamins), a placebo (i.e., 100 g of cellulose and 20 g of dextrose; CON, n = 249), both strictly offered to the animals for voluntary consumption. Treatments were offered mixed in 20 L of water within 3 h after calving. Milk data were analyzed using 2 approaches. The first, most classical, evaluated the effect of the treatments on observed milk data, whereas the second approach evaluated the effect on milk residuals (i.e., the difference between observed milk data and a prediction made by a herd test-day model). Eighty-one percent of the CAE cows fully consumed the treatment, whereas only 50% of CON cows did. No differences were detected for observed milk yield, nor for composition in multiparous cows. The only production effect observed on multiparous cows was a treatment by time interaction for milk fat yield, reflecting greater yield for CAE cows between 100 and 150 d in milk only. However, primiparous cows receiving CAE had increased milk (+0.8 kg/d) and component yields (i.e., +40 g/d of protein) compared with CON cows. These effects were more evident when milk and milk components residuals data were analyzed (i.e., +1.5 kg/d for milk yield and +57 g/d of protein). This was achieved with a herd test-day model that allowed milk and milk components data to be adjusted for environmental and genetic factors (i.e., farm effect, time effect, age at calving, parity, stage of lactation, breeding value). The treatment had no effect on the probability of reaching the next lactation (i.e., 72% of CAE cows had a next calving against 69% in CON). Primiparous cows receiving CAE had a longer calving interval compared with CON cows. At 400 d after the application of the treatment, 65% of CAE primiparous cows had a next calving, whereas 81% of CON primiparous cows had calved already. The supplementation of the tested oral Ca-energy solution at calving did not increase the probability to reach a next lactation for neither primiparous or multiparous, but positively influenced milk yield and milk component yields for primiparous.

Intravenous calcium infusion in a calving protocol disrupts calcium homeostasis compared with an oral calcium supplement.

Hypocalcemia is a common postpartum condition in dairy cows, which negatively affects health and production. Intravenous Ca infusions are commonly included in calving protocols to prevent or mitigate the effect of hypocalcemia in multiparous cows. Thus, we sought to contrast the effect of intravenous Ca infusion against voluntary oral Ca intake on Ca metabolism. Serum total Ca (tCa) and whole-blood ionized Ca (iCa) were monitored in 24 multiparous Holstein cows after parturition. Precalving diets were formulated with a positive dietary cation-anion difference of 172 mEq/kg of DM and contained 4.1 g of Ca/kg of DM. At parturition, cows were blocked by calving sequence and calcemic status as either normocalcemic (cutoff threshold of iCa ≥1.10 mmol/L) or hypocalcemic (cutoff threshold of iCa <1.10 mmol/L). Cows in each block were randomly assigned to 1 of 2 treatments: either an oral source of Ca (Ca-Oral; n = 12) or an intravenous source of Ca (Ca-IV; n = 12). Cows in the Ca-Oral group were offered a 20-L commercial Ca suspension (48 g of Ca) for voluntary consumption. The supplement contained Ca carbonate, Ca formate, Ca propionate, and other minerals and vitamins (Farm-O-San Reviva, Trouw Nutrition, Amersfoort, the Netherlands). Cows in the Ca-IV group received a 450-mL intravenous Ca solution (13 g of Ca) that contained 298 mg/mL of Ca gluconate, 33 mg/mL of magnesium chloride, and 82 mg/mL of boric acid (AmosCAL, Kommer-Biopharm BV, Heiloo, the Netherlands). Both treatments were initiated within 25 ± 10 min after calving. The oral Ca suspension was offered to cows in a 25-L bucket and was available for 10 min. All cows in the Ca-Oral group voluntarily consumed the entire 20 L of the Ca suspension within 5 min. Blood samples for Ca analyses were collected at 0 (before treatment initiation), 1, 3, 10, and 18 h relative to treatment, and at 0700 and 1900 h for the next 2 consecutive days, to represent the 24-, 36-, 48-, and 60-h sampling time points. In Ca-IV cows, both iCa and tCa concentrations peaked at 1 h (1.54 mmol/L for iCa and 2.85 mmol/L for tCa) and declined to a nadir at 24 h following treatment initiation (0.94 mmol/L for iCa and 1.74 mmol/L for tCa). Although whole-blood iCa and serum tCa were higher at 1 and 3 h in Ca-IV cows, concentrations of iCa were greater for Ca-Oral cows at 18, 24, and 36 h and for tCa at 24 and 36 h. Our data indicate that intravenous Ca infusion immediately induced a state of hypercalcemia followed by lower whole-blood iCa and serum tCa concentrations 24 h later compared with oral Ca.